Table 1. Demographic and Baseline Characteristics of the Study Cohort Divided Into the Groups Infected With Hepatitis C Virus and Not Infected With Hepatitis Virus C.
| Patients, (n = 1338) | HCV Group, (n = 1044) | Non-HCV Group, (n = 294) | P value | |
| Females, No. (%) | 204 (15.2) | 36 (3.4) | 168 (57.1) | < 0.0001 |
| Age, median (range) | 36 (32- 42) | 37 (32- 43) | 35 (31- 42) | 0.002 |
| IDU risk factor, No. (%) | 987 (73.8) | 918 (87.9) | 69 (23.5) | < 0.0001 |
| Fallow up time in month, median (range) | 43.48 (26.23 – 61.58) | 45.33 (27.74- 62.5) | 37.3 (20.6- 54.8) | 0.006 |
| CD4 cell count at base line ≤ 200 cells/μL, No. (%) | 306 (22.9) | 224 (21.5) | 82 (27.9) | 0.78 |
| > 30% decline in CD4 cell count at fallow up time, No. (%) | 145 (10.8) | 106 (10.2) | 39 (13.3) | 0.89 |
| HAART therapy, No. (%) | 0.75 | |||
| No (before 2005) | 134 (10) | 106 (10.2) | 28 (9.5) | |
| Yes (after 2005) | 1204 (90) | 938 (89.8) | 266 (90.5) |